Bilal is CEO and chief scientist for EasyKale Labs, LLC. His company pledges 2.5% of net profits to feeding the homeless, something Bilal does every Friday in Jackson, Miss., alongside volunteers for his Draw-a-Smile non-profit foundation. Another 2.5% goes to the Mississippi Coding Academies, helping at-risk kids build technology careers.
When Bilal discovered that juiced leafy kale would selectively kill melanoma cancer cells in vitro while leaving non-cancerous cells alone, he’d had a breakthrough… and a realization. The breakthrough led to a U.S. patent and continued laboratory studies. The realization was that Bilal could help humanity with a product—Bilal’s EasyKale—that makes it easy for people to add #dailykale to their diets.
Bilal has presented lectures on leadership, innovation, and his team’s cancer breakthrough at numerous conferences, most notably at the Global Health & Innovation Conference at Yale University attended by over 3,000 people. Bilal holds U.S. Patent #9919016: “Product and method of deploying kale derivatives for anti-cancer effects.” As the CEO of EasyKale Labs, he’s continuing his research into the cancer-fighting properties of kale, while offering a next-generation product for making kale consumption easier—Bilal’s EasyKale.
Kathleen Kobel is an Amazon expert seller and consultant who helps businesses grow their brands and scale their sales by selling products on Amazon.